Bleeding Complications After PCI and the Role of Transradial Access

Area of Science:

• Cardiology
• Interventional Cardiology
• Vascular Access

Background:

• Bleeding events are common and serious complications of percutaneous coronary intervention (PCI).
• Transradial (TR) catheterization is an increasingly adopted strategy to minimize bleeding and improve patient outcomes, particularly in ST-segment elevation myocardial infarction (STEMI).

Purpose of the Study:

• To evaluate the efficacy and safety of transradial (TR) catheterization compared to transfemoral (TF) approaches in PCI.
• To assess the impact of TR access on bleeding complications, clinical outcomes, and costs in STEMI patients.

Main Methods:

• Analysis of data from the RIVAL Trial comparing TR and TF approaches.
• Prospective assessment of TR access in STEMI patients via the RIFLE-STEACS Trial.
• Review of recent studies examining cost-effectiveness and radiation exposure.

Main Results:

• TR catheterization demonstrates comparable efficacy to TF with a significant reduction in vascular access complications.
• TR access in STEMI patients led to a significant reduction in the composite outcome of death/MI/stroke/revascularization/bleeding.
• TR access is associated with cost savings due to decreased hospital length of stay.
• Recent data indicate no significant difference in operator radiation exposure between TR and TF approaches in high-volume centers.

Conclusions:

• Transradial catheterization is a safe and effective alternative to transfemoral access for PCI, offering significant benefits in reducing bleeding and improving patient outcomes.
• The increasing adoption of TR access is supported by evidence of improved safety, comparable efficacy, and potential cost savings.